|Michael Feldschuh, CEO and President|
|Michael Feldschuh earned his bachelors degree in Pre-Med studies at Columbia College, Columbia University in 1991. Prior to joining Daxor’s executive team in December of 2014 he served as a member of the board of directors for one and a half years prior. Michael headed his own hedge fund, Aristarc Capital, from 2009 to 2013 specializing in quantitative strategies. Prior to founding his own fund, Michael was a Managing Director at Morgan Stanley from 2005 to 2009 and also served as a Managing Director and Portfolio Manager at Millennium Partners in New York from 1997-2005. Michael was a proprietary trader for Morgan Stanley & Co. from 1994-1997. Michael began his career at D.E. Shaw & Co. in New York, where he worked with Jeffery Bezos prior to Bezos’s founding of Amazon.|
|Jonathan Feldschuh, Chief Scientific Officer|
|Jonathan Feldschuh has been involved with developing Daxor’s technology for many years. He is a co-inventor on multiple Daxor patents, including the original patent covering the blood volume analyzer (BVA-100). Jonathan studied Physics at Harvard University, receiving an A.B. degree summa cum laude in 1986. Prior to taking on the role of CSO at Daxor, Jonathan worked extensively in technology and quantitative finance. He was the Chief Quantitative Office at Aristarc Capital, overseeing the research, development, and execution of quantitative trading strategies. Prior to Aristarc he worked in quantitative roles at financial firms such as Morgan Stanley, Millennium Partners, and American Express.|
|John Wilkens, Chief Financial Officer|
|John has over thirty years’ experience in the financial services industry. Prior to joining Convector Capital Management, John worked for sixteen years at Mark Asset Management Corp, first as the Controller and then for eleven years as Chief Financial Officer and Chief Compliance Officer. John oversaw all aspects of accounting, back office operations, compliance, administration, IT and client reporting. Prior to Mark Asset Management, John was an Assistant Vice President at Hyperion Capital Management, where he oversaw back office operations. John also worked for Crum & Forster Corp holding various positions in investment accounting, internal audit and corporate accounting.
John is a retired Major, having served in the United States Army Reserve in various leadership and staff assignments. He received a Bachelor’s degree in Accounting from Rutgers University and is a Certified Public Accountant.
|Diane Meegan, Corporate Secretary|
Diane Meegan joined DAXOR Corporation in February 2002 as the Senior Executive Assistant to the CEO and President. Ms. Meegan is currently the Corporate Secretary. Ms. Meegan served as the Official Executive Assistant to the CEO of Newbridge Securities, a wholly owned subsidiary of Citigroup, for 13 years. For 4 years, she served as a member of their Problem Review Board. In the past 2 years, she served as the Executive Assistant to the Head of Operations at Instinet Clearing Services.
|Gary Fischman, Ph.D., Vice President, R&D|
|Gary Fischman obtained his Doctor of Podiatric Medicine from the Pennsylvania College of Podiatric Medicine and his Ph.D. in Pathology from Thomas Jefferson University. He joined DAXOR in May 1998 and he comes from a background of teaching and research. He is a diplomate of the American Academy of Pain Management.|